0001806310-20-000002.txt : 20200818 0001806310-20-000002.hdr.sgml : 20200818 20200818160904 ACCESSION NUMBER: 0001806310-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200818 DATE AS OF CHANGE: 20200818 EFFECTIVENESS DATE: 20200818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc. CENTRAL INDEX KEY: 0001806310 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 843199512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-373497 FILM NUMBER: 201113721 BUSINESS ADDRESS: STREET 1: 7318 MORTON STREET CITY: DALLAS STATE: TX ZIP: 75209 BUSINESS PHONE: 212.551.8702 MAIL ADDRESS: STREET 1: 7318 MORTON STREET CITY: DALLAS STATE: TX ZIP: 75209 D 1 primary_doc.xml X0708 D LIVE 0001806310 Taysha Gene Therapies, Inc. 7318 MORTON STREET DALLAS TX TEXAS 75209 212.551.8702 DELAWARE None None Corporation true 2020 R. A. Session II 7318 Morton Street Dallas TX TEXAS 75209 Executive Officer Director Sean Nolan 7318 Morton Street Dallas TX TEXAS 75209 Director Paul B. Manning 7318 Morton Street Dallas TX TEXAS 75209 Director Sukumar Nagendran 7318 Morton Street Dallas TX TEXAS 75209 Director Suyash Prasad 7318 Morton Street Dallas TX TEXAS 75209 Executive Officer Kamran Alam 7318 Morton Street Dallas TX TEXAS 75209 Executive Officer Biotechnology Decline to Disclose 06b false 2020-07-02 false true false 0 95999816 95999816 0 false 26 0 0 0 false Taysha Gene Therapies, Inc. /s/ R.A. Session II R.A. Session II Chief Executive Officer 2020-08-17